DexCom’s growth rate has been improving, but that hasn’t been enough of a reason for investors to buy up the stock.
DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?
view original post
DexCom’s growth rate has been improving, but that hasn’t been enough of a reason for investors to buy up the stock.